Search research articles
Contact Us
Filters
Showing results (21-30 of 185) with videos related to
Page
of 19
Sort By:
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese
|
January 3, 2018
Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis
Ahmed AlTurki, Riccardo Proietti, Hasan Alturki, et al.
Journal of Cardiovascular Electrophysiology
|
April 25, 2007
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry
Matthew R Reynolds, Vidal Essebag, Peter Zimetbaum, et al.
CJC Open
|
May 29, 2020
Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure
Michelle Samuel, Michal Abrahamowicz, Jacqueline Joza, et al.
The American Journal of Cardiology
|
April 18, 2006
Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?
Joseph J Germano, Matthew Reynolds, Vidal Essebag, et al.
Journal of Cardiovascular Electrophysiology
|
July 31, 2008
Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillation
John V Wylie, Vidal Essebag, Matthew R Reynolds, et al.
The Canadian Journal of Cardiology
|
August 23, 2020
Catheter Ablation of Atrial Fibrillation: Current and Evolving Indications
Ahmed AlTurki, Jacqueline Joza, Martin L Bernier, et al.
Pacing and Clinical Electrophysiology : PACE
|
November 18, 2004
Effect of amiodarone dose on the risk of permanent pacemaker insertion
Vidal Essebag, Tom Hadjis, Robert W Platt, et al.
American Heart Journal
|
December 13, 2006
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study
Matthew R Reynolds, Tara Lavelle, Vidal Essebag, et al.
Pharmacological Research
|
March 28, 2019
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients
Ahmed AlTurki, Riccardo Proietti, Vincenzo Russo, et al.
Current Cardiology Reports
|
December 12, 2025
The New Ice Age in Electrophysiology: Ultra-Low-Temperature Cryoablation for Ventricular Tachycardia
Vadivelu Ramalingam, Elie Ganni, Katia Dyrda, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 185) with videos related to
Sort By:
Page
of 19
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese
|
January 3, 2018
Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis
Ahmed AlTurki, Riccardo Proietti, Hasan Alturki, et al.
Journal of Cardiovascular Electrophysiology
|
April 25, 2007
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry
Matthew R Reynolds, Vidal Essebag, Peter Zimetbaum, et al.
CJC Open
|
May 29, 2020
Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure
Michelle Samuel, Michal Abrahamowicz, Jacqueline Joza, et al.
The American Journal of Cardiology
|
April 18, 2006
Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?
Joseph J Germano, Matthew Reynolds, Vidal Essebag, et al.
Journal of Cardiovascular Electrophysiology
|
July 31, 2008
Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillation
John V Wylie, Vidal Essebag, Matthew R Reynolds, et al.
The Canadian Journal of Cardiology
|
August 23, 2020
Catheter Ablation of Atrial Fibrillation: Current and Evolving Indications
Ahmed AlTurki, Jacqueline Joza, Martin L Bernier, et al.
Pacing and Clinical Electrophysiology : PACE
|
November 18, 2004
Effect of amiodarone dose on the risk of permanent pacemaker insertion
Vidal Essebag, Tom Hadjis, Robert W Platt, et al.
American Heart Journal
|
December 13, 2006
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study
Matthew R Reynolds, Tara Lavelle, Vidal Essebag, et al.
Pharmacological Research
|
March 28, 2019
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients
Ahmed AlTurki, Riccardo Proietti, Vincenzo Russo, et al.
Current Cardiology Reports
|
December 12, 2025
The New Ice Age in Electrophysiology: Ultra-Low-Temperature Cryoablation for Ventricular Tachycardia
Vadivelu Ramalingam, Elie Ganni, Katia Dyrda, et al.
Page
of 19